Skip to main content

Medicare drug price negotiations may have a muted impact on drugmakers in the near term

Many of the drugs are already facing strong competition from other branded medications or patent expirations that will open the market to generic alternatives.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.